Full Yes We Cann! and Elevated States Programming Will Align, Educate, and Support New and Existing Medical Cannabis Patients
WASHINGTON, March 16, 2022 /PRNewswire/ — Today, the American Council of Cannabis Medicine (ACCM) announced that Pennsylvania is fully opening up for historic Yes We Cann! Advocacy initiative, and state centric Elevated States program this week.
“ACCM is thrilled to bring the full Yes We Cann! and Elevated States programs to Pennsylvania. We have incredible members in the commonwealth, they have a great medical-cannabis program,” says Scott Rancie, Vice President of Members Services for ACCM. “Initial outreach began, connecting with 60,000+ current medical-cannabis patients, several physicians, and dispensary managers. Like other states, people are very excited to participate in the program.”
Elevated States (state centered program) — works with Yes We Cann!, focusing on expanding physician participation and patient access through extensive outreach and education. ACCM works closely with members in each state to help educate new patients and support existing patients.
Newly expanded Elevated Membership initiative launched in Pennsylvania today. It provides extensive health and wellness programming for new and existing medical-cannabis patients. www.elevatedmembership.org/whyjoin
In February, Compassionate Certification Centers of Butler (Pennsylvania) was selected as a Distinguished Physician Partner, ACCM’s highest physician group designation. To date, only eight other physician groups have received designation across the nation. Providing a major element for launch of Pennsylvania. Thus, providing our start with a huge resource and advantage.
“We are very pleased to have been selected as the only Distinguished Partner Physician group in Pennsylvania. ACCM’s recognition of Compassionate Certification Center as a leader and innovator is an honor,” says Melonie Kotchey, Chief Executive Officer of Compassionate Certification Centers. “Our team of quality doctors and industry professionals is excited to be a part of the Elevated States initiative, helping with new patient education and existing patient support. ACCM’s commitment to helping patients is fully aligned with our vision and mission.”
Yes We Cann! began full advocacy work in fourth quarter 2021. Today, the program has had between 1.5-2 million conversations, working with over 500,000 people. The Yes We Cann! is building the nation’s largest pool of advocates to support upcoming federal legislation and state initiatives, like delivery in Pennsylvania, veteran assistance in Florida, and patient/physician access in Utah. And, the soon to be announced, Research Accelerator Compact. Yes We Cann! is supported at www.yescann.org.
“Opening our program in Pennsylvania and working to bring delivery to help patients is very exciting, it will make a huge difference, especially for seniors. We are seating a task force to get delivery done,” says Glen Caroline, Head of Advocacy, and ACfyeCM Outreach Committee Co-Chair. “We have great members in Pennsylvania and expect success with delivery and rapid expansion of Yes We Cann! there.”
The American Council of Cannabis Medicine is the “Voice of American Medical Cannabis.” ACCM represents America’s medical-cannabis industry, which supports millions of U.S. jobs and is backed by a growing grassroots movement, supporting millions of beneficiaries. Members produce, process, and distribute medical cannabis through state-licensed programs, as well as, supporting companies, healthcare industry, physicians, researchers, health/wellness providers, insurance companies, systems, and patient advocacy groups. They participate in ACCM’s 15 standing area-centric committees. ACCM was started in 2016 as a Capitol Hill working group and has developed into a mission driven 501c4. Our pressing objective is to facilitate legislation that advances medical cannabis at the federal level and improve state access.
Reach the American Council of Cannabis Medicine at 202-349-9650, or www.accmforum.org.
Media Contact
Jay Dolane
202-349-9650 ext. 800
332035@email4pr.com
SOURCE American Council of Cannabis Medicine
